Biosensors based on potent miniprotein binder for sensitive testing of SARS-CoV‑2 variants of concern
Description
The miniprotein binder TRI2-2 was employed as an antibody alternative to build a single antibody-coupled TRI2-2 based gold nanoparticle-based lateral flow immunoassay (AT-GLFIA) biosensor. The biosensor provides high specificity and affinity binding
